LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

PATIENTS WITH ACUTE CORONARY SYNDROME, ELEVATED ATHEROGENIC LIPOPROTEINS, AND PRIOR CORONARY ARTERY BYPASS GRAFTING DERIVE LARGE ABSOLUTE BENEFIT FROM ALIROCUMAB: INSIGHTS FROM THE ODYSSEY OUTCOMES TRIAL

Photo by zenmaldives from unsplash

Patients (pts) with prior CABG have extensive coronary atherosclerosis and are at increased risk for CV events and death. In the ODYSSEY OUTCOMES trial, 18,924 pts with recent ACS and… Click to show full abstract

Patients (pts) with prior CABG have extensive coronary atherosclerosis and are at increased risk for CV events and death. In the ODYSSEY OUTCOMES trial, 18,924 pts with recent ACS and elevated atherogenic lipoprotein levels (e.g., LDL≥70 mg/dL) despite high-intensity statin therapy were

Keywords: acute coronary; odyssey outcomes; outcomes trial; patients acute; elevated atherogenic

Journal Title: Journal of the American College of Cardiology
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.